BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 8704492)

  • 21. Factors associated with poor response in cognitive-behavioral therapy for pediatric obsessive-compulsive disorder.
    Storch EA; Björgvinsson T; Riemann B; Lewin AB; Morales MJ; Murphy TK
    Bull Menninger Clin; 2010; 74(2):167-85. PubMed ID: 20545494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of the efficacy of trial-based cognitive therapy for obsessive-compulsive disorder: preliminary findings.
    Rodrigues EP; Fechine AJB; Oliveira AC; Matos CFF; Passarela CM; Hemanny C; Dias FM; Batista JW; Albuquerque LCN; Soares MS; Coelho PE; Araújo VPC; Ayres ZM; de Oliveira IR
    Trends Psychiatry Psychother; 2023; 45():e20210247. PubMed ID: 35500249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of obsessive-compulsive disorder: personal follow-up of a 10-year material from an outpatient county clinic.
    Olsen T; Mais AH; Bilet T; Martinsen EW
    Nord J Psychiatry; 2008; 62(1):39-45. PubMed ID: 18389424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder.
    Storch EA; Lehmkuhl H; Geffken GR; Touchton A; Murphy TK
    Depress Anxiety; 2008; 25(2):172-4. PubMed ID: 17340610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of cognitive-behavioral therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study.
    Albert U; Aguglia A; Bogetto F; Cieri L; Daniele M; Maina G; Necci R; Parena A; Salvati L; Tundo A
    Psychother Psychosom; 2012; 81(6):383-5. PubMed ID: 22964775
    [No Abstract]   [Full Text] [Related]  

  • 26. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial.
    Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S
    BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obsessive-compulsive disorder.
    Bokor G; Anderson PD
    J Pharm Pract; 2014 Apr; 27(2):116-30. PubMed ID: 24576790
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Obsessive compulsive disorder--intrusive thoughts, impulses and repetitive behaviours as an expression of a significant disease].
    Weidt S; Rufer M; Brühl A; Baumann-Vogel H; Delsignore A
    Praxis (Bern 1994); 2013 Jul; 102(14):857-64. PubMed ID: 23823684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining Pharmacotherapy with cognitive-behavioral interventions for obsessive-compulsive disorder.
    Cottraux J; Bouvard MA; Milliery M
    Cogn Behav Ther; 2005; 34(3):185-92. PubMed ID: 16201063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of treatment response in pediatric obsessive-compulsive disorder.
    Ginsburg GS; Kingery JN; Drake KL; Grados MA
    J Am Acad Child Adolesc Psychiatry; 2008 Aug; 47(8):868-78. PubMed ID: 18596553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical predictors of long-term outcome in obsessive-compulsive disorder.
    Jakubovski E; Diniz JB; Valerio C; Fossaluza V; Belotto-Silva C; Gorenstein C; Miguel E; Shavitt RG
    Depress Anxiety; 2013 Aug; 30(8):763-72. PubMed ID: 23109056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Obsessive-compulsive disorder (OCD) in childhood].
    Puustjärvi A; Asikainen M
    Duodecim; 2010; 126(24):2855-63. PubMed ID: 21268908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A meta-analysis of dropout rates from exposure with response prevention and pharmacological treatment for youth with obsessive compulsive disorder.
    Johnco C; McGuire JF; Roper T; Storch EA
    Depress Anxiety; 2020 May; 37(5):407-417. PubMed ID: 31778595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Psychotherapy of compulsive disorder in children and adolescents--an overview].
    Simons M; Herpertz-Dahlmann B
    Z Kinder Jugendpsychiatr Psychother; 2003 Aug; 31(3):213-21. PubMed ID: 12942793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Obsessive-compulsive disorder in children and adolescents].
    Jans T; Walitza S; Warnke A
    Prax Kinderpsychol Kinderpsychiatr; 2008; 57(6):429-56. PubMed ID: 18800672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obsessive-compulsive disorder: diagnostic and treatment issues.
    Stein DJ; Denys D; Gloster AT; Hollander E; Leckman JF; Rauch SL; Phillips KA
    Psychiatr Clin North Am; 2009 Sep; 32(3):665-85. PubMed ID: 19716996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AIDS-related obsessive compulsive disorder: deconditioning based on fluoxetine-induced inhibition of anxiety.
    Kraus RP; Nicholson IR
    J Behav Ther Exp Psychiatry; 1996 Mar; 27(1):51-6. PubMed ID: 8814521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.
    Simpson HB; Foa EB; Liebowitz MR; Ledley DR; Huppert JD; Cahill S; Vermes D; Schmidt AB; Hembree E; Franklin M; Campeas R; Hahn CG; Petkova E
    Am J Psychiatry; 2008 May; 165(5):621-30. PubMed ID: 18316422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized controlled study of brief family-based intervention in obsessive compulsive disorder.
    Baruah U; Pandian RD; Narayanaswamy JC; Bada Math S; Kandavel T; Reddy YCJ
    J Affect Disord; 2018 Jan; 225():137-146. PubMed ID: 28829958
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.
    Torp NC; Dahl K; Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Hybel K; Valderhaug R; Melin K; Nissen JB; Ivarsson T
    J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):200-207.e1. PubMed ID: 25721185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.